Direct antigen presentation and chronic rejection
Hosenpud, J.D.
Circulation 99(20): 2710-2711
1999
ISSN/ISBN: 0009-7322 PMID: 10338544 Document Number: 510624
Document emailed within 1 workday
Related Documents
Hullett, D.A.; Geraghty, J.G.; Stoltenberg, R.L.; Sollinger, H.W. 1996: The impact of acute rejection on the development of intimal hyperplasia associated with chronic rejection Transplantation 62(12): 1842-1846Toma, H.; Tanabe, K.; Oba, S.; Horita, S.; Takahashi, K.; Teraoka, S.; Ota, K. 1987: Expression of class Ii antigens in human renal allografts: comparison of acute rejection, chronic rejection, and cyclosporine nephrotoxicity Transplantation Proceedings 19(5): 3719-3720
Squire, C.M.; Studer, E.J.; Lees, A.; Finkelman, F.D.; Conrad, D.H. 1994: Antigen presentation is enhanced by targeting antigen to the Fc epsilon RII by antigen-anti-Fc epsilon RII conjugates Journal of Immunology 152(9): 4388-4396
Al-Alwan, M.M.; Okkenhaug, K.; Vanhaesebroeck, B.; Hayflick, J.S.; Marshall, A.J. 2007: Requirement for phosphoinositide 3-kinase p110delta signaling in B cell antigen receptor-mediated antigen presentation Journal of Immunology 178(4): 2328-2335
Dang, L.H.; Lien, L.L.; Benacerraf, B.; Rock, K.L. 1993: A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation Journal of Immunology 150(10): 4206-4217
Kawano, Y.; Yoshizawa, I.; Baba, M.; Noma, T. 1996: Ketotifen inhibits allergen-specific T lymphocytes' responses by suppressing antigen presentation with concomitant decrease of HLA-DQ antigen on macrophages Asian Pacific Journal of Allergy and Immunology 14(2): 69-79
Mannhalter, J.W.; Neychev, H.O.; Zlabinger, G.J.; Ahmad, R.; Eibl, M.M. 1985: Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation Clinical and Experimental Immunology 61(1): 143-151
Brooks, A.G.; McCluskey, J. 1993: Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells Journal of Immunology 150(9): 3690-3697
Ma, D.I.; Wilde, D.B.; Gajewski, T.; Dunn, D.E.; Fitch, F.W. 1984: Evidence implicating I region-restricted antigen presentation in alloantigen and nominal antigen recognition by a dual-reactive helper T lymphocyte clone Journal of Immunology 133(3): 1101-1110
Gaweco, A.S.; Otto, G.; Otto, H.F.; Meuer, S.; Geisse, T.; Hofmann, W.J. 1995: Common and sequential overexpression patterns of T-helper cytokines during acute (cellular) rejection, and correlation of proinflammatory cytokine expression with chronic (ductopenic) rejection of human liver allografts: a study under cyclosporine, FK 506, and quadruple BT 563 immunosuppression Transplantation Proceedings 27(1): 1152-1154
Zimecki, M.; Kapp, J.A. 1994: Presentation of antigen by B cell subsets. IV. Defective T-B cell signalling causes inability to present antigen by B cells from immunodeficient mice Archivum Immunologiae et Therapiae Experimentalis 42(5-6): 361-367
Geppert, T.D.; Lipsky, P.E. 1985: Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression Journal of Immunology 135(6): 3750-3762
Ohtsuka, K.; Yasunami, Y.; Ikehara, Y.; Nagai, T.; Kodama, S.; Maki, T.; Tomita, A.; Abo, T.; Ikeda, S. 1997: Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment Transplantation 64(4): 633-639
Wiesner, R.H.; Porayko, M.K.; Wahlstrom, H.E.; Gores, G.J.; Kamath, P.S.; Hay, J.E.; Krom, R.A. 1993: Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection Transplantation Proceedings 25(2): 1791-1793
Takahara, S. 2002: Immunological factors for chronic rejection and the methods for the prevention of chronic allograft nephropathy Hinyokika Kiyo. Acta Urologica Japonica 48(11): 683-686
Law, L.W.; Vieira, W.D.; Kameyama, K.; Hearing, V.J. 1987: A unique tumor rejection antigen from the S91 murine malignant melanoma Cancer Research 47(22): 5841-5845
Stuart, F.P.; Fitch, F.W.; Rowley, D.A. 1970: Specific suppression of renal allograft rejection by treatment with antigen and antibody Transplantation Proceedings 2(4): 483-488
McKearn, T.J.; Finnegan, A.; Neu, M.R.; Fitch, F.W.; Stuart, F.P. 1974: Suppression of rat renal allograft rejection by antibody against lymphocyte antigen receptors Surgical Forum 25: 263-265
Suitters, A.; Rose, M.; Higgins, A.; Yacoub, M.H. 1987: MHC antigen expression in sequential biopsies from cardiac transplant patients--correlation with rejection Clinical and Experimental Immunology 69(3): 575-583
De Leo, A.B.; Becker, M.; Lu, L.; Law, L.W. 1993: Properties of a M(r) 110,000 tumor rejection antigen of the chemically induced BALB/c Meth A sarcoma Cancer Research 53(7): 1602-1607